🧠 Does late-onset MS have a distinct structural MRI signature?
Our new study compared 40 LOMS, 195 AOMS & 175 HC, showing higher lesion burden and regional gray matter atrophy in LOMS, with different MRI–clinical links vs AOMS
🔗https://t.co/nWw6Yqa5tl
#MS#MRI#Neuroimaging
Clinical, functional and cognitive features of late-onset multiple sclerosis
Our article published in the Journal of Neurology
@Nico_Ted1@paolopreziosa@agmmeani@rocca_mara
https://t.co/BDoymP6BS0
Glymphatic System May Mediate the Relation Between Choroid Plexus and Brain Damage in Multiple Sclerosis
In #MS, enlarged choroid plexus volume may contribute to brain damage through the mediation of #glymphatic system dysfunction
https://t.co/dTVJpIp75t
Advances in neuroimaging of multiple sclerosis
What are the latest breakthroughs in the application of MRI in MS?
Have a look at our review just published in Current Opinion in Neurology
#MS#MRI#research@paolopreziosa@rocca_mara
https://t.co/6WtmIJf9Bl
Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter?
Disability worsening definition in #MS patients with EDSS=5.5 varies among studies, emphasizing the need for consistency
@monicamargoni@rocca_mara
https://t.co/MjzXacm4HD
The ageing central nervous system in multiple sclerosis: the imaging perspective
A @MAGNIMS review to summarize current knowledge on the immuno-pathological and MRI aspects of ageing in the CNS in the context of MS
@Brain1878#MS#Aging#ageing#mri
https://t.co/BEtBdenLg7
The ageing central nervous system in multiple sclerosis: the imaging perspective
This @MAGNIMS review in @Brain1878 summarizes current knowledge on the immuno-pathological and MRI aspects of ageing in the CNS in the context of MS
#MS#ageing#mri
https://t.co/1pIOgLScIn